Nationwide Recall Issued for Levothyroxine Sodium Tablets Due to Potency Issues

Major Pharmaceuticals has initiated a nationwide recall of multiple lots of levothyroxine sodium tablets, a medication prescribed for thyroid conditions. The recall, announced by the FDA, is due to the drug being 'subpotent,' though further details were not immediately provided. The affected tablets include various strengths and counts.